Suchergebnisse - "Ooft, Salo N"

PubPharm (5)

1

Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer

enthalten in: Nature medicine | 2023

von van de Haar, J. | Ma, X. | Ooft, S. | +47

CommentIn: Nat Rev Gastroenterol Hepatol. 2023 May;20(5):269. - PMID 37012321

2

Multiple Low Dose (MLD) therapy: an effective strategy to treat EGFR inhibitor-resistant NSCLC tumours

enthalten in: bioRxiv.org | 2022

von Fernandes Neto, J. | Nadal, E. | Ooft, S. | +14

3

Multiple low dose therapy as an effective strategy to treat EGFR inhibitor-resistant NSCLC tumours

enthalten in: Nature communications | 2020

von Fernandes Neto, J. | Nadal, E. | Bosdriesz, E. | +15

4

Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients

enthalten in: Science translational medicine | 2019

von Ooft, S. | Weeber, F. | Dijkstra, K. | +20

CommentIn: Clin Chem. 2020 Apr 1;66(4):631. - PMID 32232458

5

Tumor Organoids as a Pre-clinical Cancer Model for Drug Discovery

enthalten in: Cell chemical biology | 2017

von Weeber, F. | Ooft, S. | Dijkstra, K. | +1

1
[1]